Antidote introduce Alzheimer’s Search Tool with GALAXY

This month Antidote have announced a partnership with Galaxy, a new online portal that offers mobile tools and resources that make it easy for patients to participate in Alzheimer’s disease research.

Antidote Match™, which uses natural language processing, artificial intelligence and an army of medical annotators to make it easy for people to find their best clinical trial matches, is now integrated into the GALAXY portal.

Data gathered during the first year of this collaboration will be used to support initiatives across the public and private sector to increase clinical research participation. This includes Antidote’s expansion to make its search tool available at no cost to all Alzheimer’s organisations, patient communities and online health portals and GALAXY’s continued work to give patients a voice in Alzheimer’s research.

Pablo Graiver, CEO & Founder of Antidote commented:
 “With so many patients needed to take part in Alzheimer’s trials, now is the perfect time to focus on transforming the way patients find, understand and take part in clinical trials. As we work with GALAXY to spread our search tool far and wide, we encourage any interested organisation to contact us to learn more about how we can work together to stem the tide of the Alzheimer’s epidemic.”

Read the full press release here.

Originally published at www.smedvigcapital.com on October 22, 2016.

Like what you read? Give Smedvig Editor a round of applause.

From a quick cheer to a standing ovation, clap to show how much you enjoyed this story.